We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$1.36B
AUM Growth
+$274M
Cap. Flow
+$256M
Cap. Flow %
18.81%
Top 10 Hldgs %
50.52%
Holding
33
New
4
Increased
25
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$28M
2
NWSA icon
News Corp Class A
NWSA
+$27.5M
3
JPM icon
JPMorgan Chase
JPM
+$23.6M
4
NVR icon
NVR
NVR
+$15.5M
5
TGNA
TEGNA Inc
TGNA
+$14.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$29.1M
2
MCD icon
McDonald's
MCD
+$16.1M
3
ABT icon
Abbott
ABT
+$11.7M
4
SBUX icon
Starbucks
SBUX
+$2.4M

Sector Composition

Rank Sector Weight
1 Financials 31.46%
2 Healthcare 25.17%
3 Consumer Discretionary 21.7%
4 Communication Services 13.31%
5 Technology 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$433B
$20.7M 1.52%
353,405
+56,464
+19% +$3.41M
SLM icon
27
SLM Corp
SLM
$5.2B
$15.8M 1.16%
1,704,266
+861,342
+102% +$8.09M
MSFT icon
28
Microsoft
MSFT
$3.68T
$13.1M 0.96%
+322,328
New +$14M
SBUX icon
29
Starbucks
SBUX
$118B
$13.1M 0.96%
314,062
-53,360
-15% -$2.4M
ABT icon
30
Abbott
ABT
$183B
-259,009
Closed -$11.7M
MCD icon
31
McDonald's
MCD
$192B
-171,419
Closed -$16.1M
MDT icon
32
Medtronic
MDT
$110B
-403,022
Closed -$29.1M

Similar funds

Smead Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Smead Capital Management held 33 positions worth $1.36B, up 25% from $1.09B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Smead Capital Management deployed $256M of net new capital in Q1 2015, opening 4 new positions and adding to 25 existing holdings. Its largest new stake was Gilead Sciences: 275,342 shares worth $27M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Starbucks, an estimated $2.4M trimmed.

  • Smead Capital Management's largest Q1 2015 buy was Gilead Sciences: 275,342 shares worth $27M.
  • Smead Capital Management added most to JPMorgan Chase in Q1 2015, an estimated $23.6M increase.
  • Smead Capital Management's biggest Q1 2015 reduction was Starbucks, cutting an estimated $2.4M.
  • Smead Capital Management fully exited Medtronic in Q1 2015, selling an estimated $29.1M.
  • Smead Capital Management's ten largest holdings make up 51% of its $1.36B portfolio in Q1 2015.
  • Smead Capital Management opened 4 new positions and closed 3 in Q1 2015.
  • Smead Capital Management's portfolio value rose 25% quarter-over-quarter to $1.36B.

Based on Smead Capital Management's 13F filing for Q1 2015, filed 8 May 2015.